Tobin Schilke - 28 Feb 2025 Form 3 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role: Chief Financial Officer
Signature: Tobin Schilke
Issuer symbol: CRNX
Transactions as of: 28 Feb 2025
Net transactions value: $0
Form type: 3
Filing time: 05 Mar 2025, 16:30:25 UTC
Previous filing: 06 Feb 2025
Next filing: 11 Mar 2025
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney. No securities beneficially owned.